Lazola, Narcisa A.
HRN: 10-05-51 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2025
AZITHROMYCIN 500MG TABLET (TAB)
11/13/2025
11/18/2025
PO
500mg
OD
CAP MR
Checking Initial Appropriateness
11/13/2025
CEFTRIAXONE 1G (VIAL)
11/13/2025
11/20/2025
IV
2g
OD
CAP MR
Checking Initial Appropriateness